Tarceva Italian Lung Optimization tRial - No Study Results Posted

Tarceva Italian Lung Optimization tRial (TAILOR)

This study is currently recruiting participants.

Study NCT00637910 Information provided by Fatebenefratelli and Ophthalmic Hospital

First Received: March 12, 2008 Last Updated: July 13, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2013
Estimated Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)

No publications provided by Fatebenefratelli and Ophthalmic Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Farina G, Longo F, Martelli O, Pavese I, Mancuso A, Moscetti L, Labianca R, Bertolini A, Cortesi E, Farris A, Fagnani D, Locatelli MC, Valmadre G, Ardizzoia A, Tomirotti M, Rulli E, Garassino MC, Scanni A. Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations. Clin Lung Cancer. 2011 Mar;12(2):138-41. Epub 2011 Apr 11.